{"passport":{"unfragile":{"@version":"1.0","version":"2026-05","artifact":{"id":"tool_amply-discovery","slug":"amply-discovery","name":"AMPLY Discovery","type":"product","url":"https://amplydiscovery.com","page_url":"https://unfragile.ai/amply-discovery","categories":["research-search"],"tags":[],"pricing":{"model":"paid","free":false,"starting_price":null},"status":"active","verified":false},"capabilities":[{"id":"tool_amply-discovery__cap_0","uri":"capability://research.biomimetic.compound.screening.and.identification","name":"biomimetic compound screening and identification","description":"Analyzes chemical structures and biological properties to identify promising drug candidate compounds by learning from natural evolutionary optimization patterns. Uses nature-inspired algorithms to score and rank compounds based on their likelihood of bioactivity.","intents":["I need to find promising lead compounds faster than traditional screening methods","I want to reduce false positives in my compound library screening","I need to identify bioactive compounds inspired by natural systems"],"best_for":["pharmaceutical R&D teams","biotech companies","drug discovery researchers"],"limitations":["Requires interpretation expertise to validate AI-identified compounds","Results must be validated through wet lab experiments","Limited to compounds with natural analogs or biomimetic properties"],"requires":["Chemical structure data (SMILES, MOL files, or similar)","Target protein or disease context information","Domain expertise to interpret results","Integration with existing drug discovery workflows"],"input_types":["chemical structures (SMILES notation)","molecular data files","target protein information","bioactivity datasets"],"output_types":["ranked compound lists","bioactivity predictions","scoring metrics","structure-activity relationship insights"],"categories":["research","drug discovery","computational chemistry"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_amply-discovery__cap_1","uri":"capability://research.nature.inspired.molecular.design.optimization","name":"nature-inspired molecular design optimization","description":"Generates and optimizes molecular structures by applying biomimetic principles derived from natural product chemistry and evolutionary systems. Suggests structural modifications to improve drug-like properties while maintaining bioactivity.","intents":["I want to optimize a lead compound while keeping it inspired by natural systems","I need to improve drug-like properties (solubility, stability, etc.) of candidate molecules","I want to generate new molecular variants based on natural product scaffolds"],"best_for":["medicinal chemists","pharmaceutical researchers","drug optimization teams"],"limitations":["Suggestions require synthetic feasibility validation","May not account for all manufacturing constraints","Optimization is constrained by nature-inspired design principles"],"requires":["Parent compound or scaffold structure","Target bioactivity and property requirements","Understanding of medicinal chemistry principles","Synthetic chemistry expertise to evaluate suggestions"],"input_types":["molecular structures","target property specifications","bioactivity thresholds","chemical constraints"],"output_types":["optimized molecular structures","property predictions","modification suggestions","comparative analysis reports"],"categories":["research","drug discovery","molecular design"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_amply-discovery__cap_2","uri":"capability://research.early.stage.drug.discovery.pipeline.acceleration","name":"early-stage drug discovery pipeline acceleration","description":"Integrates AI-powered screening and optimization into the early-stage drug discovery workflow to reduce timeline and costs. Automates the identification and prioritization of lead compounds before expensive preclinical testing.","intents":["I need to reduce the time from target identification to lead compound selection","I want to lower the cost of early-stage drug discovery","I need to de-risk my drug discovery pipeline by better compound selection"],"best_for":["pharmaceutical companies","biotech startups","contract research organizations","academic drug discovery groups"],"limitations":["Cannot replace wet lab validation and testing","Requires integration with existing discovery infrastructure","Success depends on quality of input data and target definition","Adoption requires training and process changes"],"requires":["Defined drug target or disease indication","Compound libraries or chemical databases","Existing drug discovery workflows","Cross-functional team expertise","Budget for integration and validation"],"input_types":["target information","compound libraries","bioactivity data","project parameters"],"output_types":["prioritized compound lists","timeline projections","cost estimates","risk assessments"],"categories":["research","drug discovery","workflow optimization"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_amply-discovery__cap_3","uri":"capability://research.false.positive.reduction.in.compound.screening","name":"false-positive reduction in compound screening","description":"Applies biomimetic AI algorithms to filter out compounds unlikely to have genuine bioactivity, reducing the number of false positives that would require expensive validation. Learns from evolutionary optimization to predict which compounds are truly promising.","intents":["I want to reduce wasted resources on validating compounds that won't work","I need to improve the quality of my screening results","I want to focus my wet lab efforts on the most promising candidates"],"best_for":["high-throughput screening teams","pharmaceutical researchers","biotech companies with large compound libraries"],"limitations":["Predictions are probabilistic, not deterministic","Requires sufficient training data for accuracy","May miss novel mechanisms of action","Effectiveness varies by target class"],"requires":["Historical bioactivity data","Validated screening assays","Compound structure information","Target-specific context"],"input_types":["screening results","compound structures","bioactivity data","assay parameters"],"output_types":["confidence scores","filtered compound lists","false-positive probability estimates","validation recommendations"],"categories":["research","drug discovery","quality control"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_amply-discovery__cap_4","uri":"capability://research.natural.product.inspired.compound.library.generation","name":"natural product-inspired compound library generation","description":"Creates synthetic compound libraries based on structural patterns and properties found in natural products. Generates diverse molecular variants that maintain the beneficial characteristics of natural compounds while enabling synthetic optimization.","intents":["I want to create a compound library inspired by natural products","I need to generate diverse analogs of a natural product scaffold","I want to explore chemical space around natural product structures"],"best_for":["medicinal chemists","synthetic chemists","pharmaceutical researchers","natural products researchers"],"limitations":["Generated compounds must be synthetically feasible","Library size and diversity depend on input parameters","May generate compounds with undesirable properties","Requires validation of synthetic routes"],"requires":["Natural product structures or scaffolds","Desired library size and diversity parameters","Synthetic chemistry constraints","Target property specifications"],"input_types":["natural product structures","scaffold definitions","diversity parameters","property constraints"],"output_types":["compound libraries","structure files","diversity metrics","synthetic feasibility assessments"],"categories":["research","drug discovery","library design"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_amply-discovery__cap_5","uri":"capability://research.bioactivity.prediction.for.chemical.structures","name":"bioactivity prediction for chemical structures","description":"Predicts the likelihood and potency of bioactivity for chemical compounds against specific biological targets using biomimetic AI models. Provides quantitative predictions to guide compound prioritization and selection.","intents":["I want to predict how active a compound will be against my target","I need to estimate binding affinity or potency before synthesis","I want to rank compounds by predicted bioactivity"],"best_for":["drug discovery researchers","medicinal chemists","computational chemists","pharmaceutical scientists"],"limitations":["Predictions are estimates and require experimental validation","Accuracy depends on target class and training data","May not account for off-target effects","Limited to targets with sufficient training data"],"requires":["Chemical structure data","Target protein information","Historical bioactivity data for model training","Understanding of prediction confidence intervals"],"input_types":["molecular structures (SMILES, MOL files)","target identifiers","assay type information"],"output_types":["bioactivity predictions","potency estimates","confidence scores","ranking lists"],"categories":["research","drug discovery","computational chemistry"],"confidence":0.5,"matches":0,"success_rate":0},{"id":"tool_amply-discovery__cap_6","uri":"capability://research.structure.activity.relationship.analysis","name":"structure-activity relationship analysis","description":"Analyzes relationships between chemical structure features and biological activity to identify which molecular properties drive bioactivity. Provides interpretable insights into how structural changes affect compound potency and selectivity.","intents":["I want to understand which structural features make compounds active","I need to identify key pharmacophores in my compound series","I want to learn what modifications improve or reduce activity"],"best_for":["medicinal chemists","drug discovery teams","computational chemists","structure-activity relationship specialists"],"limitations":["Requires sufficient compound series data for robust analysis","May identify correlations rather than causal relationships","Interpretability depends on data quality and diversity","Results are specific to the target and assay used"],"requires":["Series of compounds with measured bioactivity","Diverse chemical structures","Reliable bioactivity data","Domain expertise to interpret results"],"input_types":["compound structures","bioactivity measurements","assay data","chemical property data"],"output_types":["structure-activity relationship reports","pharmacophore models","feature importance rankings","modification recommendations"],"categories":["research","drug discovery","data analysis"],"confidence":0.5,"matches":0,"success_rate":0}],"trust":{"score":43,"verified":false,"data_access_risk":"low","permissions":["Chemical structure data (SMILES, MOL files, or similar)","Target protein or disease context information","Domain expertise to interpret results","Integration with existing drug discovery workflows","Parent compound or scaffold structure","Target bioactivity and property requirements","Understanding of medicinal chemistry principles","Synthetic chemistry expertise to evaluate suggestions","Defined drug target or disease indication","Compound libraries or chemical databases"],"failure_modes":["Requires interpretation expertise to validate AI-identified compounds","Results must be validated through wet lab experiments","Limited to compounds with natural analogs or biomimetic properties","Suggestions require synthetic feasibility validation","May not account for all manufacturing constraints","Optimization is constrained by nature-inspired design principles","Cannot replace wet lab validation and testing","Requires integration with existing discovery infrastructure","Success depends on quality of input data and target definition","Adoption requires training and process changes","builder identity is not verified yet","no observed match outcomes yet"],"rank_breakdown":{"adoption":0.39999999999999997,"quality":0.77,"ecosystem":0.15000000000000002,"match_graph":0.25,"freshness":0.75,"weights":{"adoption":0.25,"quality":0.25,"ecosystem":0.1,"match_graph":0.35,"freshness":0.05}},"observed_outcomes":{"matches":0,"success_rate":0,"avg_confidence":0,"top_intents":[],"last_matched_at":null},"maintenance":{"status":"active","updated_at":"2026-05-24T12:16:29.133Z","last_scraped_at":"2026-04-05T13:23:42.550Z","last_commit":null},"community":{"stars":null,"forks":null,"weekly_downloads":null,"model_downloads":null,"model_likes":null}},"distribution":{"claim_url":"https://unfragile.ai/submit?claim=amply-discovery","compare_url":"https://unfragile.ai/compare?artifact=amply-discovery"}},"signature":"UBkqWTPtZdUVgWY+UP6M/BGIXqrejt08Oe4pYnSCOemMaTIc1HDrRbNZ+hoTv9ybwDfORks3oF0l+lDNBndjAg==","signedAt":"2026-06-22T00:13:08.369Z","signedBy":"unfragile.ai","version":1},"_links":{"self":"https://unfragile.ai/api/v1/passport/amply-discovery","artifact":"https://unfragile.ai/amply-discovery","verify":"https://unfragile.ai/api/v1/verify?slug=amply-discovery","publicKey":"https://unfragile.ai/api/v1/trust-passport-public-key","spec":"https://unfragile.ai/trust","schema":"https://unfragile.ai/schema.json","docs":"https://unfragile.ai/docs"}}